Clinical Trials Browser

Phase 2 × ontuxizumab × Dermatologic × Clear all

NCT01335009 2021-09-01

Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma

Phase 2 Completed

76 enrolled 13 charts

Melanoma, Neoplasm Metastasis